ATE243028T1 - Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung - Google Patents

Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung

Info

Publication number
ATE243028T1
ATE243028T1 AT01202657T AT01202657T ATE243028T1 AT E243028 T1 ATE243028 T1 AT E243028T1 AT 01202657 T AT01202657 T AT 01202657T AT 01202657 T AT01202657 T AT 01202657T AT E243028 T1 ATE243028 T1 AT E243028T1
Authority
AT
Austria
Prior art keywords
water
production
soluble substances
granules containing
containing fat
Prior art date
Application number
AT01202657T
Other languages
English (en)
Inventor
Alberto Reiner
Original Assignee
Applied Pharma Res
Fidia Farmaceutici
Ipsen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Pharma Res, Fidia Farmaceutici, Ipsen Spa filed Critical Applied Pharma Res
Application granted granted Critical
Publication of ATE243028T1 publication Critical patent/ATE243028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
AT01202657T 2001-07-11 2001-07-11 Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung ATE243028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01202657A EP1275377B1 (de) 2001-07-11 2001-07-11 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE243028T1 true ATE243028T1 (de) 2003-07-15

Family

ID=8180628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01202657T ATE243028T1 (de) 2001-07-11 2001-07-11 Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung

Country Status (21)

Country Link
US (1) US7615547B2 (de)
EP (1) EP1275377B1 (de)
JP (1) JP2004536118A (de)
KR (1) KR100877628B1 (de)
AT (1) ATE243028T1 (de)
AU (1) AU2002328866B2 (de)
BR (1) BR0211081A (de)
CA (1) CA2452386C (de)
DE (1) DE60100389T2 (de)
DK (1) DK1275377T3 (de)
ES (1) ES2199202T3 (de)
HR (1) HRP20040010A2 (de)
IL (1) IL159346A0 (de)
MX (1) MXPA04000211A (de)
NO (1) NO20040043L (de)
NZ (1) NZ530473A (de)
PL (1) PL204963B1 (de)
PT (1) PT1275377E (de)
RU (1) RU2288704C2 (de)
WO (1) WO2003005989A2 (de)
ZA (1) ZA200309680B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579319B2 (en) 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US20050080486A1 (en) 2000-11-29 2005-04-14 Fallin T. Wade Facet joint replacement
US6419703B1 (en) 2001-03-01 2002-07-16 T. Wade Fallin Prosthesis for the replacement of a posterior element of a vertebra
US7090698B2 (en) 2001-03-02 2006-08-15 Facet Solutions Method and apparatus for spine joint replacement
US7753937B2 (en) 2003-12-10 2010-07-13 Facet Solutions Inc. Linked bilateral spinal facet implants and methods of use
US7588578B2 (en) 2004-06-02 2009-09-15 Facet Solutions, Inc Surgical measurement systems and methods
ES2327775T3 (es) * 2005-12-09 2009-11-03 Teva Pharmaceutical Industries, Ltd. Dispersiones y soluciones acuosas de compuestos dificiles de disolver y procedimientos para su preparacion.
ZA200905094B (en) 2006-12-22 2010-09-29 Yuhan Corp Revaprazan-containing solid dispersion and process for the preparation thereof
JP6216327B2 (ja) * 2011-12-22 2017-10-18 ライフ テクノロジーズ コーポレーション 細胞培地および方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
PL3641726T3 (pl) * 2017-06-23 2026-02-23 Nordiccan A/S Woreczek z kannabinoidami
CN108309933A (zh) * 2018-03-19 2018-07-24 青岛国海生物制药有限公司 一种口服醋酸甲地孕酮纳米混悬液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
JPH0449232A (ja) 1990-06-15 1992-02-18 Fujisawa Pharmaceut Co Ltd 懸濁用組成物または懸濁液並びにそれらの製造法
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
PL177323B1 (pl) 1993-10-01 1999-10-29 Syntex Inc Kompozycja farmaceutyczna zawierająca mykofenolan mofetylu lub kwas mykofenolowy i sposób wytwarzania kompozycji farmaceutycznej zawierającej mykofenolan mofetylu lub kwas mykofenolowy
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
EP0782449B1 (de) * 1994-09-22 2003-04-09 Akzo Nobel N.V. Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
FR2730163B1 (fr) 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
AU1939797A (en) 1996-03-14 1997-10-01 Shionogi & Co., Ltd. Rapid-release microdispersible ecadotril preparation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form

Also Published As

Publication number Publication date
KR100877628B1 (ko) 2009-01-07
PL204963B1 (pl) 2010-02-26
BR0211081A (pt) 2004-12-14
KR20040018440A (ko) 2004-03-03
RU2004103853A (ru) 2005-03-27
EP1275377B1 (de) 2003-06-18
DE60100389D1 (de) 2003-07-24
WO2003005989A2 (en) 2003-01-23
US7615547B2 (en) 2009-11-10
IL159346A0 (en) 2004-06-01
RU2288704C2 (ru) 2006-12-10
EP1275377A1 (de) 2003-01-15
HRP20040010A2 (en) 2004-06-30
PT1275377E (pt) 2003-11-28
ZA200309680B (en) 2004-12-22
AU2002328866B2 (en) 2007-02-15
CA2452386A1 (en) 2003-01-23
DE60100389T2 (de) 2004-05-19
CA2452386C (en) 2011-01-18
ES2199202T3 (es) 2004-02-16
WO2003005989A3 (en) 2003-05-01
DK1275377T3 (da) 2003-10-06
NZ530473A (en) 2006-02-24
JP2004536118A (ja) 2004-12-02
US20040009232A1 (en) 2004-01-15
MXPA04000211A (es) 2005-03-07
PL369294A1 (en) 2005-04-18
HRP20040010B1 (de) 2007-01-31
NO20040043L (no) 2004-01-06

Similar Documents

Publication Publication Date Title
DE60100389D1 (de) Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
ATE230979T1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
WO2003000014A3 (en) Spherical protein particles and methods of making and using them
ATE526059T1 (de) Wasserenthaltende puderzubereitung, verfahren zu deren herstellung und kosmetische zubereitung diese enthaltend
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
DK1343480T3 (da) Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler
WO2001032132A3 (en) Process for making toothpaste using agglomerated dispersible polymers
PT797987E (pt) Preparacao granular de libertacao controlada e processo para a sua preparacao
EE04740B1 (et) Meetod peroraalselt manustatava kaltsiumikompositsiooni valmistamiseks, granulaat ja tablett
DE60137452D1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
MY124599A (en) Oral suspension of pharmaceutical substance
HK1045274A1 (zh) 公式阵列及其应用
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
ATE380016T1 (de) Aufstreuverfahren zur herstellung von pulverformulierungen
BR0109802A (pt) Preparações farmacêuticas e sua fabricação
EA201001537A1 (ru) Гранулированная агрохимическая композиция и способы её получения
ATE245445T1 (de) Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen
ATE426337T1 (de) Verfahren zur herstellung von methionin-haltigen granulaten
DK1186292T3 (da) Carotenoidtörpulver med en multikernestruktur
BR0110881A (pt) Processo para a preparação de corpos sólidos inorg nicos porosos a partir de uma dispersão aquosa de partìculas, corpos sólidos inorg nicos porosos, e, uso de corpos sólidos inorg nicos porosos
FR2804046B1 (fr) Procede de preparation de particules colloidales stables fonctionnalisees et particules obtenues
BR0215134A (pt) Processo para a preparação de grânulos solúveis, isentos de pó, de compactação baixa, quimicamente estáveis de amidotioatos de fósforo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1275377

Country of ref document: EP